Organization · Venture Capital
Stoic Venture Capital
Stoic Venture Capital is a Sydney-based investment firm that partners with scientists and engineers to commercialize research and develop technologies addressing global challenges. They focus on early-stage investments in human health, advanced computing, and environmental solutions.
Overview
What Stoic Venture Capital does
What Stoic Venture Capital is
Stoic Venture Capital is a Sydney-based investment firm that partners with scientists and engineers to commercialize research and develop technologies addressing global challenges. They focus on early-stage investments in human health, advanced computing, and environmental solutions.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- May 6, 2026
Official channels
Find Stoic Venture Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Stoic Venture Capital as a funder
Investment thesis
Stoic Venture Capital backs inventors commercializing breakthrough science and engineering from Australian research, focusing on human health, advanced computing, and environmental solutions.
Focus narrative
Stoic VC invests in sectors including human health, advanced computing, and environmental solutions. They typically engage with startups that have demonstrated proof of concept (POC) of their research. The firm provides funding ranging from $100,000 to $1 million, aiming to transform research into commercially viable products.
Value beyond capital
Stoic Venture Capital provides not only funding but also strategic support to its portfolio companies, leveraging its network and expertise in commercializing research and technology. The firm emphasizes patience for long development cycles in novel therapies and deep engineering, offering lab-to-market commercial and financial support.
Terms and economics
- Typical check
- $100,000–$1,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 9
Portfolio context
Notable portfolio companies include: Kinoxis: Developing next-generation therapeutics for behavioral and cognitive disorders. Neurode: A platform for non-invasive neurostimulation and monitoring, starting with ADHD. BioScout: Technology for preventing airborne diseases in agriculture. ENA Respiratory: Developing a universal nasal spray for viral respiratory infections. Cardihab: Focused on improving cardiovascular disease management. Ferronova: Precision cancer treatment technology. Exonate: Solutions for vision loss. PERKii: Targeted release probiotic drinks. OccuRx: Novel therapies for fibrotic and inflammatory diseases related to diabetes complications.
Common questions
What to know about Stoic Venture Capital
Upseed classifies Stoic Venture Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 6, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.